Analog Devices: Roche proposes roughly $3.97M share sale
The same notice lists a cash-paid option exercise and three earlier sales of 10,000 shares each by Roche.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Analog Devices Inc. (ADI) reports that Vincent T. Roche, identified as an officer and director, gave notice of a proposed sale of 10,000 common shares, with an approximate aggregate market value of $3,969,400 and an approximate sale date of October 1, 2026. The securities information lists a cash-paid stock option exercise for 10,000 shares on that date. Roche’s reported sales in the prior three months were 10,000 shares each on July 1, August 3 and September 1, 2026.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise financial
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.